Elysium Health was founded by a trio of Americans: one esteemed scientist and researcher and two established businessmen. The scientist, Dr. Leonard Guarente, is the director of the Paul F. Glenn Center for Biology of Aging Research at the Massachusetts Institute of Technology and has worked for the institution for over thirty years. He is one of the world’s leading researchers on the molecular and genetic causes of aging.
The company’s other two founders, Dan Alminana and Eric Marcotulli, have previously been involved in investment banking and venture capital respectively. They carry out the company’s commercial operations.
The Basics of Elysium Health’s Star Product, Basis
Basis is a supplement that works to raise levels of NAD+ in the body because NAD+ levels tend to decline as people age. NAD+, or nicotinamide adenine dinucleotide, is a key coenzyme known to be essential to many of our cellular functions like energy creation and circadian rhythms. As levels of NAD+ decline those cellular functions tend to break down.
One dose of Basis is made up of 250 milligrams of nicotinamide riboside and 50 milligrams of pterostilbene.
Basis was found to increase levels of nicotinamide adenine dinucleotide by 40% in participants of a clinical study who consumed the recommended dose of Basis daily for several weeks. The results of the study were published in the scientific journal npj: Aging and Mechanisms of Disease.
Several options to purchase Basis are available if you choose to try the supplement. Individual bottles cost $60 each, containing a month’s supply of Basis. Long-term subscriptions to Basis bring the cost down to between $40 and $50 per month, depending on the length of the subscription.
More information on Elysium Health, and the science and researchers behind Basis, can be found on Elysium’s website.